Introduction
Phenylketonuria (PKU) is a group of metabolic disorders in which the amino acid phenylalanine (Phe) is highly elevated in blood (higher than 20 mg/dl or 1.2 mm) (Missiou-Tsagaraki et al., 1988) resulting in mental retardation, seizures, which are the main clinical manifestation in the untreated patients (Ludolph et al., 1996) . According to our previous in vitro studies (Tsakiris et al., 1998a; Tsakiris et al., 1998b; Schulpis et al., 1998) , Phe was found to inhibit acetylcholinesterase (AChE, EC 3.1.1.7) activity up to 20% at concentrations 1.0 to 12 mm in rat brain, in eel Electrophorus electricus AChE as well as in diaphragm. Furthermore, Wyse et al. (1995) have showed that l-alanine (Ala) reverses the inhibitory effect of Phe on Na + ,K + -ATPase (EC 3.6.1.3) activity in synaptic plasma membranes from the cerebral cortex of rat. Additionally, it has been reported that Ala reverses the inhibitory effect of Phe on other enzyme such as pyruvate kinase from liver and brain of rats (Weber, 1969) .
0939Ð5075/2002/0500Ð0506 $ 06.00 " 2002 Verlag der Zeitschrift für Naturforschung, Tübingen · www.znaturforsch.com · D Additionally, the ability of AChE to undergo ligand-induced conformational changes was first suggested by Changeux (1966) , who, by double inhibition studies, deduced the presence of "peripheral" (allosteric) anionic sites, distinct from the catalytic anionic site. The binding of ligands on peripheral sites could influence the catalytic properties of AChE. This hypothesis has been also supported by the studies of several authors (Kitz et al., 1970; Rosenbery and Bernhard, 1971) . Also, the kinetic properties of AChE have been reported to be markedly affected by the presence of both organic (Wermuth and Brodbeck, 1973; Pattison and Bernhard, 1978) and inorganic ions (Tomlinson et al., 1982; Kouniniotou-Krontiri and Tsakiris, 1984; Hughes and Bennett, 1985; PerezGuillermo et al., 1987; Tsakiris and KouniniotouKrontiri, 1988) .
Therefore, the aim of this study was to evaluate, in vitro, the effect of Ala on rat brain AChE and on eel E.electricus AChE inhibited by Phe as well as to investigate whether Phe or Ala is a competitive inhibitor or an effector using acetylthiocholine as an enzyme substrate.
Materials and Methods

Animals
For the experiments conducted on homogenized rat brain, 21 days old Albino Wistar rats of both sexes (Saint Savvas Hospital, Athens, Greece) were used. The suckling rats with their mother were housed in a cage at constant room temperature (22ð1 ∞C) under a 12 hL:12 hD (light 08.00Ð 20.00 h) cycle. Animals were cared for in accordance with the principles of the "Guide to the Care and Use of Experimental Animals" (Committee on Care and Use of Laboratory Animals, 1985) .
Tissue preparation
Animals were sacrificed by decapitation. Whole brains from six rats were rapidly removed, weighed and thoroughly washed with isotonic saline. Tissues were homogenized in 10 vol. ice-cold (0Ð4 ∞C) medium containing 50 mm Tris (hydroxymethyl) aminomethane-HCl (Tris-HCl), pH 7.4 and 300 mm sucrose using an ice-chilled glass homogenizing vessel at 900 rpm (4Ð5 strokes). The homogenate was centrifuged at 1000 ¥ g for 10 min to remove nuclei and debris. In the resulting supernatant, the protein content was determined according to the method of Lowry et al. (1951) and then the enzyme activities were measured. The enzyme incubation mixture was kept at 37 ∞C.
Amino acids (Phe, Ala, Phe plus Ala) preincubation
As it is known (Missiou-Tsagaraki et al., 1988) , the common intracellular concentration of 1.2 mm Phe in brain is 6 times lower than that found in plasma (7 mm) of phenylketonuric patients. The mean Phe levels in normal brain and plasma are 0.04ð0.01 and 0.09ð0.02 mm, respectively.
AChE activities were measured after preincubation of 1.2 mm Phe, or Ala or Phe plus Ala concentrations with 100 µg protein of whole brain homogenates or with 0.13 µg protein of eel E.electricus pure AChE (Sigma) for 1 h. The preincubation medium (about 1 ml) contained 50 mm Tris-HCl, pH 8.0 and 240 mm sucrose in the presence of 120 mm NaCl.
Determination of AChE activity
AChE activity measurements were determined on rat brain homogenates and pure enzyme (eel E.electricus) (Sigma) according to the method of Ellman et al. (1961) . The reaction mixture (1 ml) contained 50 mm Tris-HCl, pH 8.0 and 240 mm sucrose in the presence of 120 mm NaCl. Protein concentration was 80Ð100 µg/ml incubation mixture for the homogenized brain and 0.13 µg/ml for the eel E.electricus pure AChE. Then, 0.030 ml of 5,5Ј-dithionitrobenzoic acid (DTNB) and 0.050 ml of acetylthiocholine iodide, used as a substrate, were added and then the reaction started. The final concentration of DTNB and substrate were 0.125 and 0.5 mm, respectively. Moreover, AChE activities in eel E.electricus soluble enzyme were measured by using different concentrations of the substrate. K M values and n H coefficients were determined from Lineweaver-Burk and Hill plots, respectively. The enzymatic reaction was followed spectrophotometrically by the increase in absorbance (∆OD) at 412 nm.
Statistical analysis
The data are expressed as meanðSD of five separate experiments performed in triplicate. Differences between means were calculated by one way ANOVA using SPSS 7.5 statistical program on an IBM computer. P values <0.05 were considered statistically significant.
Results
As it is shown in Table I , AChE activity in rat whole brain homogenate as well as in that of eel E.electricus pure enzyme was equally inhibited (18Ð20%, p<0.01) when incubated with 1.2 mm of Phe. Lower concentrations of the amino acid induced a statistically significant minor inhibition of the enzyme activity, whereas higher concentrations (>1.2 mm) did not add further inhibitory effect on AChE (Tsakiris et al., 1998a) . On the contrary, the amino acid Ala had no effect on the enzyme activity when incubated with the previously mentioned concentration. Moreover, the presence of Ala together with Phe in the mixture of the enzymatic reaction reversed completely (p>0.05) the inhibitory effect of Phe on AChE activity. Since the obtained results of the effect of the amino acids on rat brain membrane-bound AChE as well as on that of soluble AChE were similar, we assume that Phe and Ala act directly on AChE molecule in the same way. So, we proceeded with our experiments on eel-AChE pure enzyme only. Figure 1 presents the effect of various concentrations of Ala on the inhibited AChE by Phe (1.2 mm). Ala induced a statistically significant reversion of the inhibited enzyme by Phe at concentration 0.3 mm (50% protection, p<0.05) with a maximum reversion at concentrations 1.0Ð1.2 mm of the amino acid (100% protection, p<0.01).
Furthermore, in order to investigate Ala action on the inhibited AChE by Phe, pure AChE activity was determined using different amounts of acetylthiocholine as a substrate in the presence or absence of 1.2 mm Phe, Ala, or Phe plus Ala (Fig. 2) . As it is shown in this figure, Phe was an enzyme inhibitor (50%, at 50 µm of substrate) whereas Ala an effector (50%, at the same substrate concentration). The degree of Phe inhibition and Ala stimulation on the enzyme was decreased by increasing the substrate concentration. For example at concentrations 500Ð600 µm of the substrate, Phe inhibited the enzyme activity about 20% (p<0.01), whereas Ala alone or together with Phe had no effect (p>0.05).
Moreover, the reduced AChE activity was reversed to control values in the presence of Phe plus Ala at concentrations of the substrate lower than 600 µm, while it was inhibited at higher concentrations (>600 µm) and not reversed to control values. Also, enzyme inhibition was obtained with Phe or Ala alone at high concentrations of acetylthiocholine (>600 µm). Figure 3 shows Lineweaver-Burk plots of the results presented in Fig. 2 . These plots were obtained with substrate concentrations 20Ð250 µm, in which we also observed in Fig. 2 a 100% maximum reversal effect on the enzyme activity with Phe plus Ala compared to that with Phe alone (inhibition about 50Ð30%, p<0.001). V max remained unchanged in all cases. On the contrary, the K M for the substrate was increased (about 150%, p<0.001) with Phe, decreased (about 50%, p<0.001) with Ala alone but it remained unaltered (p>0.05) when Phe plus Ala were added (see Table II ). Furthermore, the Hill plots of the results of Fig. 2 are illustrated in Fig. 4 . The Hill coefficient (n H ) remained unchanged (p>0.05) at value about 2 with Phe, Ala, or Phe plus Ala (see also Table II ).
Discussion
Our previous in vitro studies (Tsakiris et al., 1998a; Tsakiris et al., 1998b; Schulpis et al., 1998) have shown that concentration of 1.2 mm Phe, which is the common concentration in the brain of phenylketonuric patients (Missiou-Tsagaraki et al., 1988) , inhibits (20%) AChE in rat brain, in rat diaphragm and in eel E.electricus soluble enzyme in a similar way, having a direct action on AChE molecule. Our unpublished results have recently shown in vitro that high Phe concentrations (1.2 mm) preincubated with human normal erythrocyte membranes caused a higher degree (up to 40%, p<0.001) AChE inhibition. Moreover, Ala (1.2 mm) was able to reverse this enzyme inhibition by Phe to control values. Therefore, the degree of AChE inhibition by Phe is dependent on the kind of tissue. Wyse et al. (1995) have shown that Ala also reverses the inhibitory effect of Phe on Na + ,K + -ATPase activity in synaptic plasma membranes from cerebral cortex of rat. Such an action of Ala on the enzyme was assumed, when the amino acid completely reversed the inhibitory effect of Phe on AChE activity in brain and soluble enzyme (see Table I ). Therefore, Ala might reverse the inhibitory effects of Phe on brain AChE and Na + ,K + -ATPase in phenylketonuric untreated patients.
Additionally, the Lineweaver-Burk plots of the results of Fig. 2 showed in Fig. 3 that V max remained unaltered in all cases. On the contrary, the K M for the substrate was increased with Phe, decreased with Ala whereas it remained unchanged with Phe plus Ala. Therefore, Phe showed a competitive inhibitory action with the substrate whereas Ala a competitive activation. Phe and/or Ala may combine with the enzyme at a position other than the active (substrate) site. The combination of the inhibitor or the effector with the en-zyme could cause a change in the conformation (tertiary or quaternary structure) of the enzyme that may modulate the substrate site and thereby prevent (as Phe did) or promote (as Ala did) the substrate from binding. This reversal effect of Phe plus Ala on the K M value, as compared to that of Phe (Table II) , might indicate that Phe and Ala bind on the same site of the enzyme. So, Ala competition with Phe might unbind the latter from AChE molecule inducing the enzyme stimulation. If these in vitro results extend to the in vivo reality, Ala supplementation in the special therapeutic diet of the phenylketonuric patients might ameliorate the outcome of their disease.
